|
|
SAVE YOUR SPOT AT OUR SYMPOSIUM
|
|
Downstaging Strategies:
Bridging the Gap to Liver Transplantation
Monday 15th • 11:30 to 12:30 CET • Room 112
|
|
|
Prof. Maxime Ronot
University of Paris and CHU
Beaujon, Clichy, France
CHAIRMAN
|
|
Role of cTACE in
Downstaging Strategies
Dr. Marco Dioguardi Burgio
University Beaujon Hospital,
AP-HP Nord, Paris, France
|
|
|
|
Immunotherapy and
Locoregional Therapies:
Allies in Downstaging?
Dr. Richard S. Finn
Geffen School of Medicine at
UCLA, Los Angeles, USA
|
|
Immunotherapy and
Locoregional Therapies
(continuation)
Dr. Julius Chapiro
Yale School of Medicine, USA
|
|
Stage Migration in HCC: From BCLC to Real-World Practice. All speakers
|
|
|
|
|
|
DISCOVER OUR BRAND-NEW LEARNING CENTER!
|
|
Because education is key to advancing techniques, improving patient outcomes
and tackling complex clinical challenges. The destination to Education.
|
|
|
Saturday 13th & Sunday 14th Sept. (2 sessions)
|
|
|
|
15:30 - 16:15 CET
Changing the Game in HCC:
Immuno-TACE Combination
Strategies
|
|
|
|
|
|
|
|
![]() |
Hands-on experience: Create a water-in-oil emulsion using Qitexio® and test our flow model.
|
![]() |
Scientific posters to support evidence-based practice.
|
![]() |
In the Cath-Lab virtual experience.
|
![]() |
An inspiring space for sharing your challenges with peers and experts.
|
|
We look forward to connecting with you in Barcelona!
The Guerbet Team
|
|
|
Este medicamento no está registrado en España.
This information is intended for an international audience or is provided during an international event. Lipiodol® Ultra Fluid (Ethyl esters of iodized fatty
acids of poppy seed oil) is not registered in Spain.
Be aware that Indications, posology, and presentations may differ from country to country.
Countries in which cTACE indication is registered: France, Japan, South Korea, Austria, Peru, Turkey, Hungary, Czech Republic, Mongolia, Argentina &
The Netherlands.
For current and complete prescribing information refer to the local Summary of Product Characteristics (SmPC) and /or contact your local Guerbet
organization.
|
|
|
P25003735 – July 2025
|
|